Lillian Siu
机构: Princess Margaret Cancer Centre
每年引用次数
引用次数
引用: 43,648
H-指数: 106
I10-指数 : 427
出版物: 1,049
Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases.
Paul Greig , Ronald Feld , Malcolm J. Moore , Lillian L. Siu
American Journal of Clinical Oncology 29 ( 3) 225 -231
94
2006
Pharmacodynamic Evaluation of the Epidermal Growth Factor Receptor Inhibitor OSI-774 in Human Epidermis of Cancer Patients
Sarah Bacus , Michael G. Brattain , Jeffrey I. Kreisberg , Linda DeGraffenried
Clinical Cancer Research 9 ( 7) 2478 -2486
127
2003
A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with advanced solid malignancies
Daniel D. Von Hoff , Judy Moczygemba , Renaud Capdeville , S. Gail Eckhardt
Clinical Cancer Research 8 ( 7) 2157 -2166
35
2002
Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.
Ronald Drengler , Thomas Johnson , Eric K. Rowinsky , John Kuhn
Clinical Cancer Research 6 ( 9) 3459 -3468
37
2000
A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.
Frank H. Valone , Andrew Goetz , S. Gail Eckhardt , Eric K. Rowinsky
Clinical Cancer Research 8 ( 7) 2142 -2148
102
2002
Principles of clinical trial design.
Lillian L. Siu , Michelle Nottage
Journal of Clinical Oncology 20 ( 18)
34
2002
The Changing Nature of Phase I Trials
Lillian L. Siu
2016
Preliminary Results of A Phase I/IIA Study of BMS-986156 (GLUCOCORTICOID-Induced Tumour Necrosis Factor Receptor-Related Gene [GITR] AGONIST), Alone and In Combination with Nivolumab in Patients with Advanced Solid Tumours
Lillian L Siu , Neeltje Steeghs , Tarek Meniawy , Markus Joerger
Asia-pacific Journal of Clinical Oncology 13 116 -117
1
2017
Abstract PR03: Immuno-mass spectrometric identification of serum biomarkers of response and toxicity to pembrolizumab
Ihor Batruch , Antoninus Soosaipillai , Eleftherios P. Diamandis , Ioannis Prassas
Cancer immunology research 8
2020
Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial.
Christophe Massard , David A. Reardon , Jean Sebastien Frenel , Deepa S. Subramaniam
Cancer 127 ( 10) 1620 -1629
1
2021
SARS-CoV-2 vaccination and phase 1 cancer clinical trials.
Timothy A Yap , Lillian L Siu , Emiliano Calvo , Martijn P Lolkema
Lancet Oncology 22 ( 3) 298 -301
2
2021
Beyond immune checkpoint blockade: emerging immunological strategies.
Daniel V. Araujo , Tak W. Mak , Tak W. Mak , Tak W. Mak
Nature Reviews Drug Discovery 1 -21
115
2021
The Future of Clinical Trial Design in Oncology
Aaron R. Hansen , Aaron R. Hansen , Lillian L. Siu , Lillian L. Siu
Cancer Discovery 11 ( 4) 822 -837
2021
Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Harry Quon , Neha Vapiwala , Arlene Forastiere , Erin B. Kennedy
Journal of Clinical Oncology 35 ( 36) 4078 -4090
52
2017
Cetuximab (Cet) clearance and survival in patients (pts) with metastatic colorectal cancer (mCRC).
Di Maria Jiang , Hao-Wen Sim , Lillian L Siu , Jeremy David Shapiro
Journal of Clinical Oncology 35 699 -699
2017
Phase II (INSPIRE) trial of pembrolizumab (pembro) with serial immune and genomic profiling in patients (pts) with metastatic triple negative breast cancer (mTNBC).
Zachary William Neil Veitch , David W Cescon , Sawako Elston , Scott Lien
Journal of Clinical Oncology 36 1094 -1094
1
2018
Abstract A45: HPV sequencing facilitates ultrasensitive detection of HPV circulating tumor DNA
Eric Leung , Kathy Han , Jinfeng Zou , Zhen Zhao
Clinical Cancer Research 26
2020
Abstract IA15: “Next-gen” genomics-based clinical trials
Lillian L. Siu
Clinical Cancer Research 22
2016
Abstract PR03: Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials
Philippe L. Bedard , Amit Oza , Blaise Clarke , Ming-Sound Tsao
Clinical Cancer Research 22
5
2016
Integration of somatic molecular profiling for rare epithelial gynaecologic cancer patients.
Victor Rodriguez Freixinos , Stephanie Lheureux , Victoria Mandilaras , Blaise Clarke
Journal of Clinical Oncology 34 5509 -5509
1
2016